After the matching, there were 1022 matched pairs of GLP-1RA and insulin users with no significant between-group difference in the baseline characteristics except for age, hyperlipidemia, and neuropathy (Additional file 1: Table S3)
Safety Guidelines: Do not exceed 2,000 mg per day unless advised by a healthcare professional
To establish specific diets, always consult a doctor or nutritionist
The following GLP-1 (glucagon-like peptide-1) receptor agonists are FDA-approved for weight loss:[ref] Retatrutide is a GLP-1/GIP/GCG triple agonist that is currently in trials for weight loss and diabetes, showing promise for weight loss without muscle loss (2026)
Ultr2606250139 Take Advantage of our Volume Pricing
In special life situations, such as during competitive sports, diets or during pregnancy and breastfeeding, there may also be an increased need for L-carnitine and thus a deficiency